Thursday, November 6, 2025

East Midlands businesses claim £330m for R&D

East Midlands businesses claimed £330 million in research and development (R&D) tax relief for the 20/21 financial year, according to HMRC’s latest R&D tax credit statistics, analysed by tax relief specialist Access2Funding, a Ryan company.

In the East Midlands, despite business spending on R&D dropping by 10%, from £2bn to £1.8bn, there was an 8% increase in the number of claims made, from 5,595 in 19/20 to 6,045 in 20/21.

The majority of claims were made by SMEs (5,410), with 9% more claims made under the SME scheme in the East Midlands, and SMEs spending 7% more on R&D activities than the previous year.

The average R&D tax credits claim in the East Midlands was worth just under £55,000, a decrease of £5,000.

According to the report, the highest number of R&D claims were made by businesses in the Information and Communication (22%), Manufacturing (21%) and Professional, Scientific and Technical (19%) sectors.

Nigel Holmes, director of Tax at Ryan, said: “It’s refreshing to see how the East Midlands has maintained steady momentum during the Covid-19 pandemic, with more businesses making an R&D claim.

“SMEs have particularly weathered the storm, with 9% more SMEs claiming in 20/21 than 19/20 – reflecting the resilience of the region’s businesses and their ability to adapt and overcome by significantly accelerating the pace at which they innovate.

“As with the UK’s current financial pressures, R&D tax relief can help offset other rising costs and help stabilise future business growth, and the East Midlands has shown it’s in a great position to continue to go up against anything that is thrown at it and ensure that R&D is at the heart of a successful economy.”

The average claim value across the UK is sitting at approximately £74,000, or £54,000 for SMEs. There has been a 7% increase in the provisional estimated amount of claims made compared to last year, from 85,900 to 89,300, driven by a 7% rise in the number of R&D claims made by SMEs.












Latest news

Related news

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close